FDA 483 - Petnet Solutions Inc - June 24, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of PETNET Solutions South Florida in Fort Lauderdale revealed significant deficiencies in their PET drug manufacturing processes. The firm failed to demonstrate process capability through adequate media fills and lacked thorough Quality Assurance oversight during site start-up. Issues included improper handling of components, insufficient corrective actions for deviations, and inadequate controls over equipment suitability, facility contamination prevention, laboratory documentation, and production computer timestamps.
ID · b9b6a78c-31ac-43f3-9b1b-bf470d3e6972